Trends and regional disparities in triptan dispensing in France between 2014 and 2025: A nationwide open-data study
Triptan Dispensing Trends Over the years, the use of triptans, a class of drugs widely prescribed for migraine relief, has […]
Improved outcomes for patients with autonomic movement disorders originally evaluated for psychogenic non-epileptiform spells
Study Overview The investigation focuses on the outcomes for individuals diagnosed with autonomic movement disorders, particularly those who were initially
Team Approach to Functional Neurological Disorder with Traumatic Brain Injury in an Inpatient Rehabilitation Setting: A Case Report
Study Overview This case report focuses on the intricate interaction between Functional Neurological Disorder (FND) and Traumatic Brain Injury (TBI)
Association of Chronic Vascular Complications of Diabetes With Cardiovascular Autonomic Neuropathy: The Silesia Diabetes-Heart Project
Association Overview The interplay between chronic vascular complications associated with diabetes and cardiovascular autonomic neuropathy (CAN) presents a significant challenge
Team Approach to Functional Neurological Disorder with Traumatic Brain Injury in an Inpatient Rehabilitation Setting: A Case Report
Study Overview The case report focuses on a patient with functional neurological disorder (FND) who also suffered from traumatic brain
Team Approach to Functional Neurological Disorder with Traumatic Brain Injury in an Inpatient Rehabilitation Setting: A Case Report
Case Presentation In this case report, we examine an individual who experienced significant challenges following a traumatic brain injury (TBI).
Improved outcomes for patients with autonomic movement disorders originally evaluated for psychogenic non-epileptiform spells
Patient Demographics The study involved a cohort of patients diagnosed with autonomic movement disorders, characterized primarily by involuntary or abnormal
Improved outcomes for patients with autonomic movement disorders originally evaluated for psychogenic non-epileptiform spells
Clinical Characteristics of Autonomic Movement Disorders Autonomic movement disorders encompass a variety of motor disturbances that primarily result from dysfunction
Ocrelizumab Discontinuation After Recurrent Serious Infections in Clinically Stable Primary Progressive Multiple Sclerosis: A Case Report
Study Overview Ocrelizumab is a monoclonal antibody that targets CD20-positive B cells and has been primarily utilized in the treatment
Improved outcomes for patients with autonomic movement disorders originally evaluated for psychogenic non-epileptiform spells
Study Overview The investigation centers on the clinical experiences of patients diagnosed with autonomic movement disorders, specifically those initially assessed